Activating Compound | Comment | Organism | Structure |
---|---|---|---|
ATP | the enzyme is allosterically controlled by ATP, which increases its activity around 7fold through a cooperative binding mechanism | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
recombinant expression of His-tagged wild-type enzyme in Escherichia coli strain BL21 CodonPlus (DE3)-RIL | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1,4-dihydronicotinamide mononucleotide | the NADH precursor exhibits a partial mixed-type inhibition. Docking simulations suggest that all 1,4-dihydronicotinamide derivatives bind at the interdimeric interface, with the ring positioned in an unoccupied site next to the ATP binding site | Homo sapiens | |
2,2-dichloromalonate | as malonate, it binds in a small pocket of the active site | Homo sapiens | |
beta-NADH | reduced NADH inhibits the serine racemase, the inhibition is partial, the IC50 value is several-fold higher than the intracellular NADH concentrations. At saturating concentrations of NADH, ATP binds with a 2fold lower affinity and without co-operativity, suggesting ligand competition. But NADH also reduces the weak activity of human serine racemase in the absence of ATP, indicating an additional ATP-independent inhibition mechanism. The inhibitory determinant is the N-substituted 1,4-dihydronicotinamide ring. NAD+ does not seem to compete at all with NADH. Identification of the NADH-binding site, overview | Homo sapiens | |
beta-NADPH | - |
Homo sapiens | |
additional information | design of high-affinity serine racemase effectors to finely modulate D-serine homeostasis; no enzyme inhibition by ADP and the oxidized forms NAD+ and NADP+. Molecular modeling. The NADH/NAD+ fragments 1-methyl-1,4-dihydronicotinamide (MNA-red), 1,4-dihydronicotinamide mononucleotide (NMN-red), their oxidized forms 1-methylnicotinamide (MNA-ox) and beta-nicotinamide monucleotide (NMN-ox), the fully reduced form of MNA-ox-1-methyl 3-piperidinecarboxamide (MPCA), ADP and diphosphate are screened at 2 mM concentration using the beta-elimination (EC 4.3.1.17) assay to identify the inhibitory determinant of NADH, inhibition mechanism, overview | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-serine | Homo sapiens | - |
D-serine | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9GZT4 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant His-tagged wild-type enzyme from Escherichia coli strain BL21 CodonPlus (DE3)-RIL by nickel affinity chromatography | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Homo sapiens | - |
neuron | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-serine | - |
Homo sapiens | D-serine | - |
r |
Synonyms | Comment | Organism |
---|---|---|
hSR | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
assay at | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
pyridoxal 5'-phosphate | - |
Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.018 | - |
1,4-dihydronicotinamide mononucleotide | pH 8.0, 37°C | Homo sapiens | |
0.019 | - |
2,2-dichloromalonate | pH 8.0, 37°C | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.243 | - |
pH 8.0, 37°C | Homo sapiens | beta-NADH |
General Information | Comment | Organism |
---|---|---|
physiological function | human serine racemase catalyzes both the synthesis and the degradation of D-serine, an obligatory co-agonist of the glutamatergic NMDA receptors. It is allosterically controlled by ATP, which increases its activity around 7fold through a cooperative binding mechanism. Serine racemase is allosterically inhibited by NADH and reduced nicotinamide derivatives suggesting a physiological regulation of hSR activity by the glycolytic flux in neurons. NADH binding counteracts ATP activation of the enzyme with a complete loss of cooperativity | Homo sapiens |